Austrian Center for Medical Innovation and Technology (ACMIT) focuses on the development of new technologies for surgery, with special attention to minimally invasive procedures (MIP). The Perk Lab collaborates with ACMIT in research on percutaneous (through the skin) needle-based interventions used in diagnosis and treatment of solid cancers. The annual budget of the ACMIT is 4.3 million Euros. The guaranteed funding period is 4 years, to be followed by a non-competitive renewal of 3 years, contingent upon successful operation.